Design, synthesis and biological evaluation of tasiamide B derivatives as BACE1 inhibitors

被引：36

作者：

Liu, Jian ^{[1
]}

Chen, Wuyan ^{[2
]}

Xu, Yechun ^{[2
]}

Ren, Sumei ^{[1
]}

Zhang, Wei ^{[1
]}

Li, Yingxia ^{[1
]}

机构：

[1] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China

[2] Natl Ctr Drug Screening, Shanghai 201203, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2015年 / 23卷 / 09期

基金：

国家高技术研究发展计划(863计划); 中国国家自然科学基金;

关键词：

Alzheimer's disease; beta-Secretase; BACE1; inhibitor; Synthesis; Docking; AMYLOID PRECURSOR PROTEIN; HUMAN BETA-SECRETASE; CONFORMATIONAL RESTRICTION APPROACH; HUMAN BRAIN; PEPTIDOMIMETIC INHIBITORS; ASPARTIC PROTEASES; ALZHEIMERS-DISEASE; POTENT INHIBITORS; DRUG DISCOVERY; IDENTIFICATION;

D O I：

10.1016/j.bmc.2015.03.034

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Nineteen new derivatives based on the structure of marine natural product tasiamide B were designed, synthesized, and evaluated for their inhibitory activity against BACE1, a potential therapeutic target for Alzheimer's disease. The hydrophobic substituents Val at P-3 position, Leu at P-1' position, Ala at P-2' position, and Phe at P-3' position were found to significantly affect the inhibition. Free carboxylic acid at C-terminus was also found to be important to the activity. In addition, the structure-activity relationships (SARs) were supported by molecular docking simulation. (C) 2015 Published by Elsevier Ltd.

引用

页码：1963 / 1974

页数：12

共 32 条

[1]

Alejandro P., 2008, J ORG CHEM, V73, P9228

[2] A stereoselective approach to peptidomimetic BACE1 inhibitors [J].

Butini, Stefania ;

Gabellieri, Emanuele ;

Brindisi, Margherita ;

Giovani, Simone ;

Maramai, Samuele ;

Kshirsagar, Giridhar ;

Guarino, Egeria ;

Brogi, Simone ;

La Pietra, Valeria ;

Giustiniano, Mariateresa ;

Marinelli, Luciana ;

Novellino, Ettore ;

Campiani, Giuseppe ;

Cappelli, Andrea ;

Gemma, Sandra .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 70 :233-247

[3] Aspartic proteases in drug discovery [J].

Eder, Joerg ;

Hommel, Ulrich ;

Cumin, Frederic ;

Martoglio, Bruno ;

Gerhartz, Bernd .

CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (03) :271-285

[4] Design of potent inhibitors for human brain memapsin 2 (β-secretase) [J].

Ghosh, AK ;

Shin, DW ;

Downs, D ;

Koelsch, G ;

Lin, XL ;

Ermolieff, J ;

Tang, J .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (14) :3522-3523

[5] Structure-based design:: Potent inhibitors of human brain memapsin 2 (β-secretase) [J].

Ghosh, AK ;

Bilcer, G ;

Harwood, C ;

Kawahama, R ;

Shin, D ;

Hussain, KA ;

Hong, L ;

Loy, JA ;

Nguyen, C ;

Koelsch, G ;

Ermolieff, J ;

Tang, J .

JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (18) :2865-2868

[6] BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease [J].

Ghosh, Arun K. ;

Osswald, Heather L. .

CHEMICAL SOCIETY REVIEWS, 2014, 43 (19) :6765-6813

[7]

Gou T., 2006, CURR MED CHEM, V1811, P13

[8] Advances in the identification of β-secretase inhibitors [J].

Hamada, Yoshio ;

Kiso, Yoshiaki .

EXPERT OPINION ON DRUG DISCOVERY, 2013, 8 (06) :709-731

[9] Recent progress in the drug discovery of non-peptidic BACE1 inhibitors [J].

Hamada, Yoshio ;

Kiso, Yoshiaki .

EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (04) :391-416

[10] Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics [J].

Hardy, J ;

Selkoe, DJ .

SCIENCE, 2002, 297 (5580) :353-356

← 1 2 3 4 →